Standout Papers

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biop... 2017 2026 2020 2023 711
  1. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD (2017)
    Hannes Hagström, Patrik Nasr et al. Journal of Hepatology

Immediate Impact

3 from Science/Nature 67 standout
Sub-graph 1 of 17

Citing Papers

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Interferon- γ and infectious diseases: Lessons and prospects
2024 StandoutScience
3 intermediate papers

Works of Ulf Hammar being referenced

Daily adjunctive therapy with vitamin D3 and phenylbutyrate supports clinical recovery from pulmonary tuberculosis: a randomized controlled trial in Ethiopia
2018
Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long‐term follow‐up study
2017
and 3 more

Author Peers

Author Last Decade Papers Cites
Ulf Hammar 378 1140 218 577 409 67 2.2k
Sonia Román 233 1034 209 786 550 128 2.5k
Dorit Nitzan 329 1244 455 297 845 71 2.9k
Arnoldo Riquelme 559 864 266 335 435 136 2.6k
Fatma M. Shebl 296 689 122 448 210 99 2.4k
Guglielmo M. Trovato 284 597 217 185 357 86 1.6k
Sanjay Rampal 413 774 362 197 666 95 2.8k
Steve Shaw 360 681 108 664 106 64 3.1k
David Price 108 933 228 206 231 105 2.8k
Iain M. Murray‐Lyon 115 1348 230 1210 111 96 3.0k
P. Mercié 141 604 194 176 166 121 2.8k

All Works

Loading papers...

Rankless by CCL
2026